serw-MX  [xml]  
 


    
 DeCS Categories

C04 Neoplasms .
C04.588 Neoplasms by Site .
C04.588.322 Endocrine Gland Neoplasms .
C04.588.322.400 Multiple Endocrine Neoplasia .
C04.588.322.400.500 Multiple Endocrine Neoplasia Type 1 .
C04.588.322.400.505 Multiple Endocrine Neoplasia Type 2a .
C04.651 Neoplasms, Multiple Primary .
C04.651.600 Multiple Endocrine Neoplasia .
C04.651.600.500 Multiple Endocrine Neoplasia Type 1 .
C04.651.600.505 Multiple Endocrine Neoplasia Type 2a .
C04.700 Neoplastic Syndromes, Hereditary .
C04.700.630 Multiple Endocrine Neoplasia .
C04.700.630.500 Multiple Endocrine Neoplasia Type 1 .
C04.700.630.505 Multiple Endocrine Neoplasia Type 2a .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.320 Genetic Diseases, Inborn .
C16.320.700 Neoplastic Syndromes, Hereditary .
C16.320.700.630 Multiple Endocrine Neoplasia .
C16.320.700.630.500 Multiple Endocrine Neoplasia Type 1 .
C16.320.700.630.505 Multiple Endocrine Neoplasia Type 2a .
C19 Endocrine System Diseases .
C19.344 Endocrine Gland Neoplasms .
C19.344.400 Multiple Endocrine Neoplasia .
C19.344.400.500 Multiple Endocrine Neoplasia Type 1 .
C19.344.400.505 Multiple Endocrine Neoplasia Type 2a .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Multiple Endocrine Neoplasia .
Adenomatosis, Multiple Endocrine .
Familial Endocrine Adenomatosis .
Multiple Endocrine Adenomatosis .
Multiple Endocrine Adenopathy .
Multiple Endocrine Neoplasia Syndromes .
Multiple Endocrine Neoplasms .
Adenomatoses, Familial Endocrine .
Adenomatoses, Multiple Endocrine .
Adenopathies, Multiple Endocrine .
Adenopathy, Multiple Endocrine .
Endocrine Adenomatoses, Familial .
Endocrine Adenomatoses, Multiple .
Endocrine Adenomatosis, Familial .
Endocrine Adenomatosis, Multiple .
Endocrine Adenopathies, Multiple .
Endocrine Adenopathy, Multiple .
Endocrine Neoplasms, Multiple .
Familial Endocrine Adenomatoses .
Multiple Endocrine Adenomatoses .
Multiple Endocrine Adenopathies .
Adenomatosis, Familial Endocrine .
Endocrine Neoplasia, Multiple .
Neoplasia, Multiple Endocrine .
Neoplasms, Multiple Endocrine .
A group of autosomal dominant diseases characterized by the combined occurrence of tumors involving two or more ENDOCRINE GLANDS that secrete PEPTIDE HORMONES or AMINES. These neoplasias are often benign but can be malignant. They are classified by the endocrine glands involved and the degree of aggressiveness. The two major forms are MEN1 and MEN2 with gene mutations on CHROMOSOME 11 and CHROMOSOME 10, respectively. .
1.00
682088
 
Multiple Endocrine Neoplasia Type 1 .
Multiple Endocrine Neoplasia Type I .
Multiple Endocrine Neoplasms Type 1 .
Neoplasms, Multiple Endocrine Type I .
Neoplasia, Multiple Endocrine Type 1 .
Neoplasms, Multiple Endocrine Type 1 .
Wermer Syndrome .
A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the PARATHYROID GLANDS, the PITUITARY GLAND, and the PANCREATIC ISLETS. The resulting clinical signs include HYPERPARATHYROIDISM; HYPERCALCEMIA; HYPERPROLACTINEMIA; CUSHING DISEASE; GASTRINOMA; and ZOLLINGER-ELLISON SYNDROME. This disease is due to loss-of-function of the MEN1 gene, a tumor suppressor gene (GENES, TUMOR SUPPRESSOR) on CHROMOSOME 11 (Locus: 11q13). .
0.86
441614
 
Multiple Endocrine Neoplasia Type 2a .
MEA 2a .
MEA II .
MEA IIa .
MEN II .
MEN IIa .
MEN-2A Syndrome .
MEN2a .
Multiple Endocrine Neoplasia Type 2 .
Multiple Endocrine Neoplasia, Type IIa .
Multiple Endocrine Neoplasms Type 2a .
Pheochromocytoma And Amyloid-Producing Medullary Thyroid Carcinoma .
MEN 2A Syndrome .
MEN-2A Syndromes .
Pheochromocytoma And Amyloid Producing Medullary Thyroid Carcinoma .
MEN 2 .
MEN 2a .
Neoplasia, Multiple Endocrine Type 2a .
Neoplasms, Multiple Endocrine Type 2a .
Sipple Syndrome .
A form of multiple endocrine neoplasia characterized by the presence of medullary carcinoma (CARCINOMA, MEDULLARY) of the THYROID GLAND, and usually with the co-occurrence of PHEOCHROMOCYTOMA, producing CALCITONIN and ADRENALINE, respectively. Less frequently, it can occur with hyperplasia or adenoma of the PARATHYROID GLANDS. This disease is due to gain-of-function mutations of the MEN2 gene on CHROMOSOME 10 (Locus: 10q11.2), also known as the RET proto-oncogene that encodes a RECEPTOR PROTEIN-TYROSINE KINASE. It is an autosomal dominant inherited disease. .
0.86